169303 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING T CELL PROLIFERATION IN A SUBJECT IN NEED THEREOF
#602METHOD FOR MEASURING FIBRINOGEN CONCENTRATION IN BLOOD SAMPLE AND NANOPARTICLES FOR SAME
#603MEASUREMENT OF MOLECULAR INTERACTIONS AT SINGLE MOLECULE LEVEL USING SUBSTRATES THAT ENHANCE FLUORESCENCE DETECTION
#604Methods and compositions for targeting polyubiquitin
#605METHODS FOR DETERMINING A DRUG DOSING REGIMEN
#606Device and method for chemical analysis
#607Test strip for detecting microalbumin in urine with high sensitivity
#608KIT FOR QUICKLY DETECTING CADMIUM CONTENT IN SAMPLE
#609Automated sample quality assessment
#610METHODS RELATED TO A STRUCTURE OF HIGH-AFFINITY HUMAN PD-1/PD-L2 COMPLEX
#611Plasma/serum separator device and methods using the same
#612Single-cell analysis chip for anticancer drug combination
#613ASSAY PANELS
#614RENAL CANCER DETECTION METHOD AND TEST DRUG
#615Plasmonic biosensor
#616Lectin Assay For Assessing Glycoforms As An Early Marker In Disease
#617METHOD AND KIT FOR ASSISTING DIAGNOSIS OF DISEASE IN SUBJECT
#618Aromatic-cationic peptides and uses of same
#619BIOLOGICAL STATUS CLASSIFICATION
#620Anti-TIM-3 antibodies and uses thereof
#621CD8A-binding fibronectin type III domains
#622Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions
#623Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#624Read through of truncated proteins in premature termination codon diseases using an optimized genetic codon expansion system
#625Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#626Expression cassette and host cell for expressing a Vip3-interacting protein
#627Administering methylation-controlled J protein (MCJ) SIRNA to a kidney cell
#628METHOD OF PREDICTING AND DETERMINING THERAPEUTIC EFFECT ON RHEUMATOID ARTHRITIS DUE TO BIOLOGICAL FORMULATION
#629ANTIGEN TREATMENT METHOD
#630Methods of detecting polyubiquitin using anti-polyubiquitin antibodies
#631Method for predicting the risk of obesity in a subject
#632METHOD FOR SELECTING HIGHLY EFFICIENT STEM CELL, USING PROTEIN MARKER GRP78
#633Anti-claudin 18.2 antibodies
#634Methods for labelling, analyzing, detecting and measuring protein-protein interactions
#635Method for improving quality of therapeutic cell through real-time glutathione measurement
#636Genetically encoded biosensors
#637High affinity monoclonal antibodies for detecting amanitins
#638REAGENT KIT, MEASUREMENT KIT, AND MEASUREMENT METHOD
#639CD153 AND/OR CD30 IN INFECTION
#640Diagnostics systems and methods
#641CHIRAL PEPTIDES
#642IRS MODULATORS
#643Biomarker sampling in the context of neuromodulation devices, systems, and methods
#644Insecticidal proteins and methods for their use
#645METHODS AND REAGENTS FOR REDUCING THE INTERFERENCE OF DRUGS THAT BIND CD47 IN SEROLOGICAL ASSAYS
#646METHOD FOR DETERMINING ELIGIBILITY OF BRAIN TUMOR PATIENT FOR TAILOR-MADE TYPE PEPTIDE VACCINE AGENT
#647Extracellular vesicles purified from dried blood cards
#648Metabolic biomarker set for assessing ovarian cancer
#649Systems and methods for determining a chemical state
#650Peptide mapping method for sequence identification of insulin and insulin analogues
#651Bed bugs detection device
#652Laboratory instrument, system and method for instrument-controlled treatment of at least one laboratory sample using at least one consumable
#653Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
#654Anti-STAT3 bispecific antibody having cell-penetrating ability, and pharmaceutical composition containing same
#655GRP78-derived peptide for identifying high-efficiency stem cells
#656Peptidomimetics, method of synthesis and uses thereof
#657TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING TRAMETINIB
#658Method for measuring quality of therapeutic cell through real-time glutathione measurement
#659Temperature and humidity chamber type apparatus for taking potential impact marks and method using the same
#660Expression systems and methods of use thereof
#661METHODS TO PREVENT TERATOGENICITY OF IMID LIKE MOLECULES AND IMID BASED DEGRADERS/PROTACS
#662MEDICINE FOR TISSUE REGENERATION, AND PREPARATION METHOD THEREFOR
#663Fibronectin binding domains with reduced immunogenicity
#664Highly Sensitive System and Method for Analysis of Troponin
#665Eukaryotic translation initiation factors (EIFS) as novel biomarkers in head and neck squamous cell carcinoma (HNSCC)
#666Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
#667Compositions and methods for enhanced fluorescence
#668Modulation of Aminopeptidase N/CD13 and Rheumatoid Arthritis
#669Epitope-targeted peptide immunostimulants
#670Method for Detecting Human Soluble Asialoglycoprotein Receptor
#671POLYMER-BASED SIGNAL AMPLIFICATION FOR PROTEIN AND CELL DETECTION
#672Random heteropolymers preserve protein function in foreign environments
#673System and method for identification of a synthetic classifer
#674METHOD FOR DIAGNOSING CANCER FROM BLOOD
#675Medical test card
#676Phosphate and tensin homolog (PTEN) for the detection of autoimmune diseases or conditions
#677MOLECULAR SIGNATURE FOR SELECTING LYMPHOMA PATIENTS FOR TREATMENT WITH IBRUTINIB
#678COMPOSITION FOR PREDICTING OR DIAGNOSING LIVER DISEASE, AND LIVER DISEASE PREDICTION OR DIAGNOSIS METHOD USING SAME
#679Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#680Human β2-glycoprotein I expression
#681Method for treating complications related to acute or chronic hyperglycemia
#682Method of producing a novel animal model for tauopathies
#683Modeling ribosome dynamics to optimize heterologous protein production
#684Bicarbonate biosensors, calcium biosensors, and uses thereof
#685RAPID TEST FOR CELLULAR FIBRONECTIN
#686C3B INACTIVATING POLYPEPTIDE
#687COMPOUND SEARCH METHOD, INFORMATION PROCESSING APPARATUS, AND RECORDING MEDIUM RECORDING COMPOUND SEARCH PROGRAM
#688IN-VITRO METHOD AND KIT FOR DIAGNOSING THE RISK OF SUFFERING FROM CARIES
#689BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#690USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT
#691METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING AUTOPHAGY
#692Techniques for processing of mass spectral data
#693METHOD FOR DETECTING PROSTATE CANCER
#694Compositions and methods for enhanced fluorescence
#695Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#696Systems and methods for performing a real-time glycan assay of a sample
#697DEGRON FUSION CONSTRUCTS AND METHODS FOR CONTROLLING PROTEIN PRODUCTION
#698Means and methods for single molecule peptide sequencing
#699Antibodies specific for sclerostin and methods for increasing bone mineralization
#700Active MMP9-binding peptide
#701INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASES
#702ANTIBODY PURIFICATION AND PURITY MONITORING
#703Methods for administering angiotensin II
#704Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
#705Signature of TL1A (TNFSF15) signaling pathway
#706Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
#707Enhanced RNA interactome capture (eRIC)
#708NEUKINASE, A DOWNSTREAM PROTEIN OF NEUREGULIN
#709Antibody-mediated neutralization of ebolaviruses
#710Food allergen detection device and methods of use thereof
#711Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies
#712BIOMARKER FOR DIAGNOSING DEPRESSION AND USE OF BIOMARKER
#713MUTANT PROTEINS AND METHODS FOR THEIR PRODUCTION
#714Methods for detecting sinusoidal obstructive syndrome (SOS)
#715Method of Evaluating Nutriture
#716COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#717Protease and binding polypeptide for O-glycoproteins
#718ERBB2/HER2 MUTATIONS IN THE TRANSMEMBRANE OR JUXTAMEMBRANE DOMAIN
#719SYSTEM AND METHODS FOR MULTIPLEXED ANALYSIS OF CELLULAR AND OTHER IMMUNOTHERAPEUTICS
#720Artificial proteins and compositions and methods thereof
#721Inflammasome activation in myelodysplastic syndromes
#722Methods for diagnosing and treating inflammatory bowel disease
#723Method for modifying surface of polymer substrate and polymer substrate having surface modified thereby
#724Detection of bioprosthetic valve degeneration
#725Detection of serum methionine and glucose by graphite pencil electrode
#726INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
#727Anti-lap antibody variants
#728Peptide libraries with non-canonical amino acids
#729NOVEL PROTEINS AND USE THEREOF
#730Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#731Compositions and methods for treating cancer
#732Method for assessing validity of cell therapy product
#733Lysyl Oxidase-Like 2 Assay
#734BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES
#735Fibronectin binding domains with reduced immunogenicity
#736COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE THEREOF
#737Method and system for the non-destructive in ovo determination of fowl gender
#738FATTY ACID BINDING PROTEIN 3 FOR THE ASSESSMENT OF ATRIAL FIBRILLATION (AF)
#739MENSTRUAL CUP HAVING BLOOD TEST CARTRIDGE
#740METHOD FOR TREATING INTESTINAL GLUTAMINE SYNTHETASE ACTIVITY DEFICIENCY
#741Polypeptide and use thereof
#742INHIBITORS OF PROTEINS SPECIFIC FOR THE SECRETOME OF A CHONDROCYTE FOR USE IN THE TREATMENT OF BREAST CANCER METASTASIS
#743Compositions, methods, and systems for affinity-based protein identification and purification
#744Neuromodulation techniques
#745Method for Detecting Glycoprotein
#746Enzymes for Glycan Analysis
#747Ligands for integrin αVβ8, synthesis and uses thereof
#748Biomarkers for early diagnosis and differentiation of mycobacterial infection
#749Methods and systems for diagnosing diseases
#750Anti-CD47 monoclonal antibody and use thereof
#751Method of identifying l/m-opsin and CRX positive cone photoreceptor cells based on specific biomarkers
#752INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ASPARAGINYL TRNA SYNTHETASES
#753COMPOSITION FOR USE IN DETECTING AN ALLERGY TO CLAVULANIC ACID
#754Amphipathic molecule based on tandem malonate and use thereof
#755Method for recovering extracellular vesicles
#756Epitope tag and method for detection and/or purification of tagged polypeptides
#757Bioparticle measuring method
#758Bioparticle measuring method
#759Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#760Vedolizumab for the treatment of fistulizing Crohn's disease
#761Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#762REAGENT COMPOSITION FOR MEASURING GLYCATED ALBUMIN AND METHOD FOR MEASURING GLYCATED ALBUMIN USING SAME
#763Compositions and methods for allergen detection
#764Unstructured non-repetitive polypeptides having LCST behavior
#765Glypican-3 peptide reagents and methods
#766CANCER BIOMARKERS
#767Biomaterials for neuronal implants and use of said biomaterials in the diagnosis and therapy of neuronal diseases
#768Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels
#769System and method for determining the effectiveness of medications using genetics
#770PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#771Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#772PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#773PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#774PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#775Methods and compositions useful in detecting proteins
#776Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein
#777Methods of selecting therapeutic molecules
#778Assessment of stability of biological product in prefilled syringes
#779COPANLISIB BIOMARKERS
#780Systems and methods for immunomodulation of mucosal-associated invariant T cells
#781Norbornene-based amphipathic compound and utilization thereof
#782Movable type method applied to protein-ligand binding
#783Genetically encoded biosensors
#784Activity sensor with tunable analyte
#785TIM-3 antibody, antigen binding fragment thereof, and medicinal uses thereof
#786Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#787Engineered Cyclic Peptides
#788Anti-GPC3 antibody
#789Galectin-10 antibodies
#790Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
#791METHODS AND COMPOSITIONS FOR FEEDING PIERCING AND SUCKING INSECTS
#792Molecular design to suppress desorption of self-assembled monolayers
#793Recombinant protein production system
#794Anti-GPC3 antibody
#795Liver-type fatty acid-binding protein standard, method for evaluating standard, method for regulating variation range of measured value caused by liver-type fatty acid-binding protein in measurement using standard, liver-type fatty acid-binding protein, DNA encoding protein, cell transformed by DNA, method of producing protein, method of drawing calibration curve for liver-type fatty acid-binding protein, and method of quantifying protein
#796Pre-assembled, protected, chemically stable, chemoselective linkers
#797Method of detecting biological material, and chemiluminescent indicator used therein
#798Detection of a biomarker in a sample of a flowable substance
#799Data-processing device for chromatograph
#800METHODS OF SELECTING SUBJECTS FOR COMBINATION CANCER THERAPY WITH A POLYMER-CONJUGATED SOLUBLE PH20
#801ELISA assay for measuring function of properdin and kits for conducting ELISA assays using anti-properdin antibodies
#802Peptoid compound, and derivative, salt, preparation method and use thereof
#803Preparation of recombinant tetrameric N-acetylated alpha-synuclein
#804PROTEIN MELT ANALYSIS USING DIPYRROMETHENEBORON DIFLUORIDE COMPOUNDS
#805Application of ERH Gene in the Preparation of Bladder Cancer Diagnosis and Treatment Products
#806MEASUREMENTS OF PROTEIN-PROTEIN INTERACTIONS AT SINGLE MOLECULE LEVEL
#807Nucleic acid taggants
#808Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
#809Method and composition for a protein transduction technology and its applications
#810BIOTHIOL DETECTION COMPOSITION COMPRISING REDOX REGULATION PROTENIN
#811Biomarker test and method for assessing mucosal healing in response to treatment of ulcerative colitis
#812GENETICALLY ENCODED BIOSENSORS
#813DEVICES, METHODS, AND KITS FOR MULTIPLEXING A FLUID SAMPLE VIA FLUID SAMPLE REUSE
#814leukocidins, therapeutic compositions, and uses thereof
#815Method and kit for detecting concentration of factor H
#816Anti-PD1 monoclonal antibody, pharmaceutical composition thereof and use thereof
#817USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT
#818Thyroglobulin quantitation by mass spectrometry
#819Kidney disease prognosis prediction method and system
#820Method of Identifying Transmembrane Protein-interacting Compounds
#821Device and method for chemical analysis
#822IL-13 antibody and preparation method and use thereof
#823Immunoassay for collagen type VI
#824Engineered potent cytotoxic stapled BH3 peptides
#825Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies
#826MOLECULAR SENSOR FOR NMR/MRI BASED ON ANALYTE-DEPENDENT SPECTRAL CHANGES OF TEMPORARILY ENCAPSULATED HYPERPOLARIZED 129XE
#827Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
#828BIOCHIP AND METHOD FOR MANUFACTURING BIOCHIP
#829Allergen detection method
#830Methods for determining lymphocyte receptor chain pairs
#831ANIMALS, CELLS, LIGANDS, POLYPEPTIDES & METHODS
#832Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization
#833GROWTH HORMONE RECEPTOR DEFICIENCY CAUSES A MAJOR REDUCTION IN PRO-AGING SIGNALING, CANCER AND DIABETES IN HUMANS
#834Microchip capillary electrophoresis assays and reagents
#835Tris- or neopentyl glycol-based amphiphiles and uses thereof
#836MACROPHAGES REDIRECT PHAGOCYTOSIS BY NON-PROFESSIONAL PHAGOCYTES AND INFLUENCE INFLAMMATION
#837SOLUBLE ST2 FOR THE IDENTIFICATION OF PROGRESSORS TO LVH IN THE GENERAL POPULATION
#838INTERROGATORY CELL-BASED ASSAYS AND USES THEREOF
#839Biomarker SBP1 for early diagnosis of kidney diseases, and use thereof
#840Methods for detecting genetically modified organisms (GMO)
#841Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition
#842Screening method for laminin 511 production promoting agent, basal epidermal layer stabilizing agent, and/or epidermal stem cells reduction inhibiting or proliferation promoting agent
#843Transferrin receptor transgenic models
#844Identifying new therapeutic agents
#845Lactoferrin aptamers and use thereof
#846SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein
#847Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Histidyl-tRNA synthetases
#848Sequence of antibody heavy chain constant region for enhancing agonistic antibody activity
#849Determinants of cancer response to immunotherapy
#850METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#851Cancer-treating pharmaceutical composition inhibiting expression of CCND3 or PAK2 gene
#852Therapeutic oligonucleotides
#853Anti-human ninjurin-1 (NINJ-1) antibodies and methods for detecting human NINJ-1
#854RECOMBINANT PROTEINS DERIVED FROM GENUS LIMULUS, AND DNA MOLECULES ENCODING SAME
#855Fluorescent dye and preparation method and use thereof
#856NON-INVASIVE METHODS OF DETECTING TARGET MOLECULES
#857Silanized ITO electrode with ITO nanoparticles for aqueous sulfide detection
#858Methods of identifying modulators of SAMTOR-GATOR1 interaction and use of same to modulate mTORC1
#859Methods for identifying proteins that bind ligands
#860Method for screening antibody using patient-derived tumor spheroids
#861Prevention and treatment of diabetic nephropathy
#862METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION
#863Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#864Apolipoprotein E isotype detection by mass spectrometry
#865Evaluating method of ketosis in postpartum dairy cows
#866Reagent diluent
#867Molecule sensor systems
#868Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels
#869Specific monoclonal antibody to acetylated mouse BubR1 and preparation method therefor
#870Targeting dimerization of BAX to modulate BAX activity
#871Compositions and methods for the treatment of neurodamage
#872Signaling and antigen-presenting bifunctional receptors (SABR)
#873α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#874Bedbug detection, monitoring and control techniques
#875HEATING APPARATUS FOR DEVELOPING LATENT IMPACT MARK
#876Tryptophan oxidase and use thereof
#877Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereof
#878IDENTIFICATION AND PRODUCTION OF HIGH AFFINITY IGM ANTIBODIES AND DERIVATIVES THEREOF
#879Diagnosis, prevention, and/or treatment of autoimmune diseases
#880Systems and methods for characterization of molecules
#881In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use
#882Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Modulating Bile Acid Homeostasis in a Subject Having Nonalcoholic Fatty Liver Disease
#883Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Modulating Bile Acid Homeostasis in a Subject Having Liver Fibrosis
#884Methods of using compositions comprising variants of FGF19 polypeptides for reducing bile acid synthesis in a subject having cirrhosis
#885GSK3B and uses thereof in the diagnostic and treatment of hypopigmentation disorders
#886Diagnostic Test to Exclude Significant Renal Injury
#887Application of anaplasma phagocytophilum protein APH1384
#888Anti-polyubiquitin multispecific antibodies
#889Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
#890AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF
#891METHOD FOR MONITORING GLUTAMINE SYNTHETASE LEVELS
#892METHOD FOR MONITORING FETUS/PRETERM INFANT DEVELOPMENT, AND FOR PROMOTING THE NORMAL DEVELOPMENT OF PRETERM INFANTS
#893Process for preparing immunoglobulin compositions
#894Method for Determining Stage of Periodontal Disease
#895Genes and uses for plant improvement
#896Methods for modulating insect hygro- and/or thermosensation
#897FUSION PROTEIN OF C2 DOMAIN AND AKT KINASE DOMAIN FRAGMENT AND USE THEREOF
#898Chiral peptides
#899Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
#900Methods and uses for remotely triggered protease activity measurements